I. N. Olver
Impact in
- Oncology top 10%
- Cancer survivorship and care
- Cancer Treatment and Pharmacology
- Lung Cancer Research Studies
Papers in ⓘ
- Co-authors
- Guy C. Toner (6 shared papers)Euan Walpole (4 shared papers)Alan S. Coates (1 shared paper)P. Grantley Gill (1 shared paper)David Thomson (1 shared paper)Michael Friedländer (3 shared papers)Peter Hersey (1 shared paper)Richard Kefford (1 shared paper)
- Journals
- Journal of Clinical Oncology (2 papers)European Journal of Cancer (2 papers)Annals of Oncology (2 papers)Seminars in Oncology (1 paper)The Lancet (1 paper)
- Partner nations
- AustraliaNew ZealandUnited States
In The Last Decade
I. N. Olver
17 papers receiving 486 citations
Peers
Comparison fields: 5 of 73
- Oncology 242
- Reproductive Medicine 38
- Surgery 171
- Neurology 57
- Pulmonary and Respiratory Medicine 107
Countries citing papers authored by I. N. Olver
This map shows the geographic impact of I. N. Olver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. N. Olver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. N. Olver more than expected).
Fields of papers citing papers by I. N. Olver
This network shows the impact of papers produced by I. N. Olver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. N. Olver. The network helps show where I. N. Olver may publish in the future.
Co-authors
The 25 scholars most cited alongside I. N. Olver, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1993 | 118 | |
| 2 | 2001 | 75 | |
| 3 | 1997 | 63 | |
| 4 | 1996 | 61 | |
| 5 | 1984 | 43 | |
| 6 | Paclitaxel as first-line treatment for metastatic breast cancer. The Taxol Investigational Trials Group, Australia and New Zealand. | 1997 | 28 |
| 7 | 2012 | 26 | |
| 8 | 1985 | 22 | |
| 9 | 1980 | 16 | |
| 10 | 2007 | 13 | |
| 11 | 1992 | 11 | |
| 12 | 1995 | 10 | |
| 13 | 1997 | 7 | |
| 14 | A randomized study of paclitaxel versus cyclophosphamide/methotrexate/5-fluorouracil/prednisone in previously untreated patients with advanced breast cancer : Preliminary results | 1997 | 6 |
| 15 | 2007 | 3 | |
| 16 | 1997 | 1 | |
| 17 | 1983 | 1 |
About I. N. Olver
I. N. Olver is a scholar working on Oncology, Surgery, Molecular Biology, Pulmonary and Respiratory Medicine and Dermatology, having authored 17 papers that have together received 504 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (4 papers), Nausea and vomiting management (3 papers), Breast Cancer Treatment Studies (2 papers), Cancer therapeutics and mechanisms (2 papers), Anesthesia and Pain Management (2 papers), Chemotherapy-related skin toxicity (2 papers), Lung Cancer Research Studies (2 papers) and Sarcoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Oncology (242 citations), Reproductive Medicine (38 citations), Surgery (171 citations), Neurology (57 citations) and Pulmonary and Respiratory Medicine (107 citations). I. N. Olver has collaborated with scholars based in Australia, New Zealand and United States. Frequent co-authors include Guy C. Toner, Euan Walpole, Alan S. Coates, P. Grantley Gill, David Thomson, Michael Friedländer, Peter Hersey, Richard Kefford, R. John Simes and James F. Bishop. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Annals of Oncology, Seminars in Oncology and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.